Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
暂无分享,去创建一个
C. la Vecchia | E. Negri | U. Pastorino | M. Boeri | C. Verri | D. Conte | P. Suatoni | G. Sozzi | N. Sverzellati | A. Marchianò | L. Roz | F. Bravi | M. Rossi | M. Grassi | A. Marchiano
[1] S. Lam,et al. EarlyCDT-Lung: An Immunobiomarker Test as an Aid to Early Detection of Lung Cancer , 2011, Cancer Prevention Research.
[2] Nicola J. Armstrong,et al. Haemolysis during Sample Preparation Alters microRNA Content of Plasma , 2011, PloS one.
[3] Yingye Zheng,et al. Prospective Accuracy for Longitudinal Markers , 2007, Biometrics.
[4] U. Pastorino,et al. Role of MicroRNAs in Lung Cancer: MicroRNA Signatures in Cancer Prognosis , 2012, Cancer journal.
[5] D. Berry,et al. Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.
[6] F. Su,et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.
[7] David Machin,et al. Survival Analysis: A Practical Approach , 1995 .
[8] G. Illei,et al. The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes , 2012, PloS one.
[9] Patrick Maisonneuve,et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer , 2011, EMBO molecular medicine.
[10] T. Lumley,et al. Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.
[11] E. Kroh,et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.
[12] S. Ramsey,et al. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.
[13] E. Kroh,et al. Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies , 2011, Cancer Prevention Research.
[14] P. Sestini. Reduced lung-cancer mortality with CT screening. , 2011, The New England journal of medicine.
[15] J. Peres. Lung cancer screening gets risk-specific. , 2013, Journal of the National Cancer Institute.
[16] A. Dirksen,et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT , 2012, Thorax.
[17] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[18] Ugo Pastorino,et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[19] A. Jemal,et al. Global Cancer Statistics , 2011 .
[20] Armando Santoro,et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. , 2009, American journal of respiratory and critical care medicine.
[21] C. Croce,et al. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review , 2012, EMBO molecular medicine.
[22] Ugo Pastorino,et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer , 2011, Proceedings of the National Academy of Sciences.
[23] B. Burwinkel,et al. Characterization of extracellular circulating microRNA , 2011, Nucleic acids research.
[24] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[25] M. Roizen. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[26] C. Chiles. Lung cancer screening with low-dose computed tomography. , 2014, Radiologic clinics of North America.
[27] P. Bach,et al. Reduced lung-cancer mortality with CT screening. , 2011, The New England journal of medicine.